SCHEMBL14022908

SCHEMBL14022908

Bc1cccc2ccsc12

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.50
DAO P14920 1/20 0.38
HDAC4 P56524 1/20 0.37
PIM1 P11309 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CYP19A1 P11511 2/20 0.33
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ATR Q13535 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
OPRM1 P35372 1/20 0.30
OPRK1 P41145 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12432195 0.76 CYP2A6 (0.46) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL594318 0.71 CYP2A6 (0.50) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL3799554 0.71 CYP2A6 (0.50) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL276295 0.71 CYP2A6 (0.55) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL911242 0.71 CYP2A6 (0.50) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL156699 0.71 CYP2A6 (0.50) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL389275 0.71 CYP2A6 (0.50) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL1866237 0.71 CYP2A6 (0.50) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL2011067 0.71 CYP2A6 (0.50) CYP2A6DAOHDAC4PIM1SLC6A2
SCHEMBL5869169 0.71 CYP2A6 (0.50) CYP2A6DAOHDAC4PIM1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008144222-A2 TRIAZOLYL AMINOPYRIMIDINE COMPOUNDS ELI LILLY AND COMPANY (US) 2008-11-27 WO disclosed
WO-2008144223-A2 TRIAZOLYL AMINOPYRIMIDINE COMPOUNDS ELI LILLY AND COMPANY (US) 2008-11-27 WO disclosed